PCN114 COST-EFFECTIVENESS ANALYSIS OF PEMETREXED/CISPLATIN IN THE FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN ITALY: RESULTS FOR THE ADENOCARCINOMA HISTOLOGY SUB-POPULATION
L Guidi, S Malik, D Valle, Y Asukai, K TaipaleVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74365-5
File:
PDF, 93 KB
english, 2009